Navigation Links
Omeros is Not Aware of Any Justification for Share Price Movement
Date:11/13/2012

SEATTLE, Nov. 13, 2012 /PRNewswire/ -- Omeros Corporation (NASDAQ: OMER) has noted the fall in its share price over the last week of trading.  Omeros is not aware of any reason that justifies this decrease. As disclosed in Omeros' recent press releases and its Quarterly Report on Form 10-Q filed on November 9, 2012 with the US Securities and Exchange Commission, Omeros' business, including its clinical programs and its preclinical pipeline, remains on track and the Company is pleased with its progress.

About Omeros Corporation
Omeros is a clinical-stage biopharmaceutical company committed to discovering, developing and commercializing products targeting inflammation, coagulopathies and disorders of the central nervous system. The Company's most clinically advanced product candidates are derived from its proprietary PharmacoSurgery™ platform designed to improve clinical outcomes of patients undergoing a wide range of surgical and medical procedures. Omeros has four ongoing clinical development programs. Omeros may also have the near-term capability, through its GPCR program, to add a large number of new drug targets and their corresponding compounds to the market. Behind its clinical candidates and GPCR platform, Omeros is building a diverse pipeline of protein and small-molecule preclinical programs targeting inflammation, coagulopathies and central nervous system disorders.


'/>"/>
SOURCE Omeros Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Omeros to Present at Deutsche Bank Securities Health Care Conference
2. Omeros Adds Four More Unlocked Orphan GPCRs to its Portfolio
3. Omeros to Present at Jefferies 2012 Global Healthcare Conference
4. Omeros Announces Proposed Public Offering of Common Stock
5. Omeros Prices $30 Million Public Offering of Common Stock
6. Omeros Announces Closing of $34.5 Million Public Offering of Common Stock
7. Omeros Successfully Completes Preclinical Studies of OMS824 for Schizophrenia and Phase 1 Clinical Trial Preparations Underway
8. Omeros Announces Discovery in MASP-2 Program
9. Omeros Corporation Reports Second Quarter 2012 Financial Results
10. Omeros Announces Completion of Enrollment in OMS103HP Phase 3 Clinical Trial
11. Omeros to Present at Two Upcoming Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2014)... 28, 2014  ALPHAEON Corporation ® ... and subsidiary of Strathspey Crown Holdings ... Nutriceuticals (PRN) ® , a leading developer ... for dry eye and macular degeneration, ... worth up to $55M. ...
(Date:7/28/2014)... , SINGAPORE, and TOKYO , July ... that it has appointed Roger Crystal , MD ... recently served in the Global Business Development Product Acquisition ... "Roger,s experience in developing business strategy and partnerships ... as we continue to partner with biotechnology and pharmaceutical ...
(Date:7/28/2014)... MURRAY HILL and NEW PROVIDENCE, ... management and engineering professionals are invited to meet with ... Conference and Technical Exhibition to be held at McCormick ... August 3-6. "Hospitals demand nothing less ... said Mark Sanda , Linde,s Healthcare Segment manager. ...
Breaking Medicine Technology:ALPHAEON Acquires PRN, A Leading Specialty Nutriceutical Company 2ALPHAEON Acquires PRN, A Leading Specialty Nutriceutical Company 3ImaginAb Appoints Roger Crystal, MD as Vice President of Business Development 2Linde's Healthcare division to display new Hospital Services platform at the national ASHE Conference in Chicago 2
... Calif., April 2, 2012 No matter the advances that ... are suffering with tooth damage and decay every single day. According ... percent of all adults as well as 16 percent of ... the integrity and appearance of smiles, the most trusted ...
... Calif., April 2, 2012 Fortis Healthcare, ... hospitals across the country, and Masimo (NASDAQ: ... technology supplier agreement that allows Fortis hospitals access to ... pulse oximetry and noninvasive, continuous patient monitoring solutions. ...
Cached Medicine Technology:Northridge Cosmetic Dentists, Dr. Michel Elyson and Dr. Ramin Assili, are Now Offering Advanced Tooth Colored Restorations to Restore Smiles 2Fortis Healthcare Signs Agreement Giving India's Fastest-Growing Hospital Chain Access to Masimo's State-of-the-Art Noninvasive Patient Monitoring Solutions 2Fortis Healthcare Signs Agreement Giving India's Fastest-Growing Hospital Chain Access to Masimo's State-of-the-Art Noninvasive Patient Monitoring Solutions 3Fortis Healthcare Signs Agreement Giving India's Fastest-Growing Hospital Chain Access to Masimo's State-of-the-Art Noninvasive Patient Monitoring Solutions 4Fortis Healthcare Signs Agreement Giving India's Fastest-Growing Hospital Chain Access to Masimo's State-of-the-Art Noninvasive Patient Monitoring Solutions 5Fortis Healthcare Signs Agreement Giving India's Fastest-Growing Hospital Chain Access to Masimo's State-of-the-Art Noninvasive Patient Monitoring Solutions 6Fortis Healthcare Signs Agreement Giving India's Fastest-Growing Hospital Chain Access to Masimo's State-of-the-Art Noninvasive Patient Monitoring Solutions 7Fortis Healthcare Signs Agreement Giving India's Fastest-Growing Hospital Chain Access to Masimo's State-of-the-Art Noninvasive Patient Monitoring Solutions 8
(Date:7/28/2014)... live near green spaces deliver babies with significantly ... "Green Spaces and Adverse Pregnancy Outcomes" published in ... , A team of researchers from Israel and ... evaluated nearly 40,000 single live births from a ... determine the impact of green surroundings during pregnancy ...
(Date:7/28/2014)... July 28, 2014 With California in ... is welcome news that a fire blanket ... protection is under development by SunSeeker Enterprises, Inc. The ... protect spacecraft from the extreme heat of re-entry into ... firefighters and homes. , “Our firefighters routinely lay their ...
(Date:7/28/2014)... The report “Industrial Enzymes Market ... Beverages, Cleaning Agents, Bio-Fuel, Animal Feed), & Geography ... and segments the global industrial enzymes market with ... industrial enzymes. It also identifies driving and restraining ... analysis of trends, opportunities, burning issues, winning imperatives, ...
(Date:7/28/2014)... The University of Texas Health Science Center at San Antonio, ... combination of pills that cures 9 of 10 hepatitis C ... with or without ribavirin, cured 93 percent of patients in ... the study published today in The Lancet . ... Eric Lawitz, M.D., clinical professor in the School of Medicine ...
(Date:7/28/2014)... Recent research has shown the cumulative impact of ... lead to a range of health problems including obesity, ... desk, or an adjustable sit-to-stand desk, commonly leads to ... to a seated position. , The new Standing ... leg pain and fatigue while working upright. These durable ...
Breaking Medicine News(10 mins):Health News:Revolutionary Fire Blanket Offers Over 200 Percent More Fire Protection to Firefighters and Homes 2Health News:Industrial Enzymes Market Worth $5,987.5 Million by 2018 - Report by MarketsandMarkets 2Health News:Industrial Enzymes Market Worth $5,987.5 Million by 2018 - Report by MarketsandMarkets 3Health News:Industrial Enzymes Market Worth $5,987.5 Million by 2018 - Report by MarketsandMarkets 4Health News:New pill regimens published in The Lancet cure hardest-to-treat hepatitis C patients 2Health News:New Standing Desk Anti-fatigue Mats from Martinson-Nicholls Reduce Leg Fatigue and Discomfort Working at Standing and Sit-to-Stand Desks 2
... contributed by our work is its relevance to population ... discover survival related to cancer in a more precise ... and researcher in the Epidemiology Service of the Department ... The investigation, which has been published in the ...
... "happy families are all alike; every unhappy family is unhappy ... unhappy families, in fact, are unhappy in two distinct ways. ... a host of specific difficulties for children during their early ... for children as they enter school, or they can be ...
... international bans, more than 250,000 children fight as soldiers ... them in Africa. Two new studies explored how these ... to successful adaptation, the studies found, was the characteristics ... In the first study, researchers found that former child ...
... Anderson Cancer Center remains the leading hospital in the nation for ... "Best Hospitals" survey published by U.S. News & World Report. ... MD Anderson has ranked number one in the annual listing. Since ... of the top two cancer hospitals in the United States. ...
... HealthDay Reporter , WEDNESDAY, July 14 (HealthDay ... and rheumatoid arthritis shows promise as an option to ... blood vessels, according to two new studies. The ... current standard, cyclophosphamide, in treating antineutrophil cytoplasmic antibody ...
... , TORONTO, ON On the eve of the world,s ... review shows many people wouldn,t get inoculated against HIV even ... published in this month,s edition of the journal AIDS ... the University of Toronto,s Factor-Inwentash Faculty of Social Work. Newman ...
Cached Medicine News:Health News:The probability of surviving nine types of cancer is analyzed 2Health News:Behavior problems in school linked to 2 types of families 2Health News:Behavior problems in school linked to 2 types of families 3Health News:Studies explore effects of war on former child soldiers 2Health News:Studies explore effects of war on former child soldiers 3Health News:Studies explore effects of war on former child soldiers 4Health News:MD Anderson keeps No. 1 cancer ranking in US News & World Report annual survey 2Health News:MD Anderson keeps No. 1 cancer ranking in US News & World Report annual survey 3Health News:Rare Blood Vessel Disease Could Have New Treatment Option 2Health News:Rare Blood Vessel Disease Could Have New Treatment Option 3Health News:Future HIV vaccines: If we build it, will they come? 2
... Finn Revision Knee System ... distal femoral replacement options. The ... Finn Rotating Hinge Knee, promotes ... function and is designed for ...
The Advance stemmed medial-pivot knee is a revision knee that provides unique and competitive features....
... The NexGen Legacy LCCK Femoral Component ... additional prosthetic stabilization due to inadequate ... and require augmentation and/or stem extensions ... NexGen LCCK is available with a ...
The Duracon system provides superb articular conformity throughout the range of motion, reducing contact stresses generally associated with wear....
Medicine Products: